MRNA
ModernaPrevious close
145.62
Change
+1.85 / +1.29%
52-Week Range
22.28 – 176.66
P/E (TTM)
—
Forward P/E
—
Market Cap
$58.1B
1M
+125.91%
S&P 500 −2.41% over same period
Volume / Avg Volume
8.8M / 11.5M
0.77× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-31 | $145M | -1.97 / -2.12 | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-01 | $389M | -3.40 / -4.04 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-12 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-11-06 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-01 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-01 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
A 5-year P/E range needs a longer earnings record; not yet comparable
No buybacks or dividends in the last four quarters
P/E (TTM)
—
P/B
8.5
P/S
25.8
PEG
—
Earnings Reaction
Over the last 6 reports, the stock moved ±4.2% on average on the first trading day after, rising 6 times
Most recent +0.58%
Volatility & Correlation
1-year beta 1.87 · Correlation with S&P 500 0.13High beta
Annualized volatility 192% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 6 · $49.2MNet selling $49.2M
- 09-15Hoge StephenPresidentSell$5.9M40,281 shares · Avg price 146.07
- 09-14Hoge StephenPresidentSell$5.8M40,294 shares · Avg price 144.13
- 09-10Mock James MChief Financial OfficerSell$4.7M34,836 shares · 2 trades · Avg price 134.49
- 09-01Klinger Shannon ThymeChief Legal OfficerSell$0.49M3,471 shares · Avg price 139.95
- 08-05Bancel StephaneChief Executive OfficerSell$28.7M499,246 shares · 4 trades · Avg price 57.52
- 07-15Hoge StephenPresidentSell$3.6M53,336 shares · Avg price 67.60
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 0.15 | +2.1% | 35.9% | -0.78 | -1.97 |
| FY2026 Q1 | 0.39 | +260.2% | -145.5% | -1.34 | -3.40 |
| FY2025 Q4 | 0.68 | −29.8% | 33.3% | -0.83 | -2.10 |
| FY2025 Q3 | 1.02 | −45.4% | 79.6% | -0.20 | -0.51 |
| FY2025 Q2 | 0.14 | −41.1% | 16.2% | -0.83 | -2.13 |
| FY2025 Q1 | 0.11 | −35.3% | 16.7% | -0.97 | -2.52 |
| FY2024 Q4 | 0.97 | −65.6% | 23.5% | -1.12 | -2.91 |
| FY2024 Q3 | 1.86 | +1.7% | 72.4% | 0.01 | 0.03 |
| FY2024 Q2 | 0.24 | −29.9% | 52.3% | -1.28 | -3.33 |
| FY2024 Q1 | 0.17 | −91.0% | 42.5% | -1.18 | -3.07 |
| FY2023 Q4 | 2.81 | −44.7% | 67.0% | 0.22 | 0.63 |
| FY2023 Q3 | 1.83 | −45.6% | -22.4% | -3.63 | -9.53 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| MRNA | — | +2.1% | 35.9% | +125.91% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |